Feed / LNTH

Lantheus Holdings, Inc.

LNTH

Healthcare · 99.99 -0.3% today

Partial group confirmationMarket checked 21 Aug, 15:55 GMT-4

Jodie situation report

Lantheus Holdings, Inc.'s move is being confirmed by its market group.

LNTH accounts for 1.1% of the group's measured movement across 5.6 effective names. raw member direction is mixed; 7 of 12 session-normalized paths align to the upside. Capital-flow agreement is 16%, so confirmation is not yet clean. No verified headline preceded the measured group move.

MOVE ANATOMY

Is this move genuinely shared?

Session-normalized 5m paths
Role in the moveFlat / inactive path#11 of 12 by movement share
Group movement share1.1%Absolute path energy—not portfolio weight
Relative path-0.24%flat
Effective breadth5.6 / 12balanced
Relative alignment7/12upside path · 1 counter-moving
Capital-flow agreement16%not yet clean
SEQUENCE READ

No material onset for LNTH could be timestamped inside the aligned 5-minute window.

What changed
  • Revenue increased 2.7% versus the comparable filing period.
  • Gross margin fell 1.4 percentage points.
EVIDENCE COVERAGE

10 of 16 members in Clinical Biopharmaceuticals are active. 0 of 8 disclosed connections are confirming.

What would change this read
  • At least 11 of 16 durable members become active together.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as NBIX begins moving with the group.

Invalidation: The live read weakens if participation falls to 5 of 16 members or fewer.

Watch this read

Who this business touches

The relationships behind LNTH

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

MOLNFiling-linked nameinvesteeFeb 26, 2026 ▾

“Previously, on July 3, 2024,we acquired from Life Molecular the global rights to RM2, its clinical stage, gastrin-releasing peptide receptor (“GRPR”)-targeting agent, including the associated novel, clinical-stage radiotherapeutic and radiodiagnostic pair, pr…”

LTGHYFiling-linked nameinvesteeNov 6, 2025 ▾

“On July 21, 2025, we acquired Life Molecular pursuant to a Sale and Purchase Agreement, dated as of January 12, 2025, with Life Medical Group Limited (the “Seller”) and Life Healthcare Group Holdings Limited (the “Sale and Purchase Agreement”).”

Depended on by

CATXPerspective Therapeutics, Inc.partnerMay 11, 2026 ▾

“Option Agreement On January 8, 2024, the Company entered into an option agreement (Option Agreement) with Lantheus whereby Lantheus was granted an exclusive option to negotiate an exclusive, worldwide, royalty- and milestone-bearing right and license to [ 212…”

Filing peers

SNDXNXRTBEAM

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 13 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

LNTH is currently a Participant in the organic co-movement group Clinical Biopharmaceuticals. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.